Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Medicine, Hualien Armed Forces General Hospital, Hualien, Taiwan.
Eur J Heart Fail. 2024 Feb;26(2):199-207. doi: 10.1002/ejhf.3155. Epub 2024 Jan 30.
There are no studies on the association between secondhand smoke (SHS) exposure and incident heart failure (HF). This cohort study aimed to examine the associations of self-reported and urinary cotinine-assessed SHS exposure with incident HF.
This study included 5548 non-active smoking participants aged 45-84 years and free of known cardiovascular diseases and HF at baseline who self-reported SHS exposure time in the Multi-Ethnic Study of Atherosclerosis (MESA) at baseline (2000-2002). A cohort subset of 3376 non-active smoking participants underwent urinary cotinine measurements. HF events were verified by medical records or death certificates and ascertained from baseline through 2019. Multivariable Cox proportional hazards regression analysis was used with adjustment for demographic variables, traditional cardiovascular risk factors, physical activity, tobacco pack-years and medications. During a median follow-up of 17.7 years, 353 and 196 HF events were identified in the self-report cohort and cohort subset, respectively. In the self-report cohort, compared with the SHS unexposed group (0 h/week), the highest tertile of the SHS exposed group (7-168 h/week) was not associated with incident HF (hazard ratio [HR] 0.70, 95% confidence interval [CI] 0.49-1.00; p = 0.052). In contrast, in the cohort subset, participants with detectable urinary cotinine >7.07 ng/ml had a higher risk of incident HF than those with undetectable urinary cotinine ≤7.07 ng/ml (HR 1.45, 95% CI 1.03-2.06; p = 0.034). There were no significant heterogeneities in HF risk by age, sex, race/ethnicity, or past smoking status.
Secondhand smoke exposure reflected by modestly increased urinary cotinine (>7.07 ng/ml) rather than self-report in non-active smokers was associated with a 40-50% higher risk of any HF event.
目前尚无研究探讨二手烟暴露与心力衰竭事件之间的关联。本队列研究旨在探讨自我报告的二手烟暴露和尿可替宁评估的二手烟暴露与心力衰竭事件之间的相关性。
本研究纳入了 5548 名年龄在 45-84 岁之间、无已知心血管疾病和心力衰竭病史的非主动吸烟参与者,他们在基线时(2000-2002 年)通过多民族动脉粥样硬化研究(MESA)自我报告了二手烟暴露时间。队列的一个子集包括 3376 名非主动吸烟参与者,他们进行了尿液可替宁检测。通过医疗记录或死亡证明来验证心力衰竭事件,并从基线开始至 2019 年进行随访。多变量 Cox 比例风险回归分析用于调整人口统计学变量、传统心血管危险因素、体力活动、吸烟包年数和药物。在中位数为 17.7 年的随访期间,自我报告队列和队列子集分别确定了 353 例和 196 例心力衰竭事件。在自我报告队列中,与未暴露于二手烟的组(每周 0 小时)相比,暴露于二手烟的最高 tertile 组(每周 7-168 小时)与心力衰竭事件无关(风险比[HR]0.70,95%置信区间[CI]0.49-1.00;p=0.052)。相比之下,在队列子集中,尿液可替宁检测值大于 7.07ng/ml 的参与者发生心力衰竭事件的风险高于尿液可替宁检测值小于或等于 7.07ng/ml 的参与者(HR 1.45,95%CI 1.03-2.06;p=0.034)。按年龄、性别、种族/民族或既往吸烟状况分层后,心力衰竭风险无显著异质性。
在非主动吸烟者中,尿液可替宁适度增加(>7.07ng/ml)反映的二手烟暴露而不是自我报告的二手烟暴露与任何心力衰竭事件的风险增加 40-50%相关。